<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Community:</title>
    <link>http://www.dspace.cam.ac.uk:80/handle/1810/221765</link>
    <description />
    <pubDate>Fri, 24 May 2013 13:22:35 GMT</pubDate>
    <dc:date>2013-05-24T13:22:35Z</dc:date>
    <item>
      <title>Gene structure and expression of serotonin receptor HTR2C in hypothalamic samples from infanticidal and control sows</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/242393</link>
      <description>Title: Gene structure and expression of serotonin receptor HTR2C in hypothalamic samples from infanticidal and control sows
Authors: Quilter, Claire R; Bagga, Meenashki; Moinie, Ahmad; Junaid, Fatima; Sargent, Carole A
Abstract: Abstract Background The serotonin pathways have been implicated in behavioural phenotypes in a number of species, including human, rat, mouse, dog and chicken. Components of the pathways, including the receptors, are major targets for drugs used to treat a variety of physiological and psychiatric conditions in humans. In our previous studies we have identified genetic loci potentially contributing to maternal infanticide in pigs, which includes a locus on the porcine X chromosome long arm. The serotonin receptor HTR2C maps to this region, and is therefore an attractive candidate for further study based on its function and its position in the genome. Results In this paper we describe the structure of the major transcripts produced from the porcine HTR2C locus using cDNA prepared from porcine hypothalamic and pooled total brain samples. We have confirmed conservation of sites altered by RNA editing in other mammalian species, and identified polymorphisms in the gene sequence. Finally, we have analysed expression and editing of HTR2C in hypothalamus samples from infanticidal and control animals. Conclusions The results confirm that although the expression of the long transcriptional variant of HTR2C is raised in infanticidal animals, the overall patterns of editing in the hypothalamus are similar between the two states. Sequences associated with the cDNA and genomic structures of HTR2C reported in this paper are deposited in GenBank under accession numbers FR720593, FR720594 and FR744452.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Sun, 01 Apr 2012 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/242393</guid>
      <dc:date>2012-04-01T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Pluripotency-associated genes in human nasopharyngeal carcinoma CNE-2 cells are reactivated by a unique epigenetic sub-microenvironment</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/242180</link>
      <description>Title: Pluripotency-associated genes in human nasopharyngeal carcinoma CNE-2 cells are reactivated by a unique epigenetic sub-microenvironment
Authors: Cao, Jun-Xia; Cui, Yu-Xin; Long, Zi-Jie; Dai, Zhong-Min; Lin, Ji-Yan; Liang, Yi; Zheng, Fei-Meng; Zeng, Yi-Xin; Liu, Quentin
Abstract: Abstract Background There is increasing evidence that cancers contain their own stem-like cells, and particular attention has been paid to one subset of cancer-stem cells termed side population (SP). Stem cells under normal physical conditions are tightly controlled by their microenvironment, however, the regulatory role of the microenvironment surrounding cancer stem cells is not well characterized yet. In this study we found that the phenotype of SP can be "generated" by macrophage-like cells under conditioned culture. Furthermore the gene regulation pathway involved in cellular reprogramming process was investigated. Methods The selection and identification of SP in 50 CNE-2 single cell clones were performed by flow cytometry. The transwell assay and immunofluorescence staining were used to measure migration and cancer stem cell characters of non-SP single clone cells cultured with conditioned medium respectively. The subtraction suppression hybridization (SSH) technique and northern blotting analysis was applied to explore the pluripotency-associated genes under a unique epigenetic sub-microenvironment. Results Among 50 clones, only one did not possess SP subpopulation while others did. The non-SP cells induced by macrophage-like cells showed more aggressive characters, which increased cell migration compared with the control cells and showed some fraction of SP phenotype. These cells expressed distinguished level of pluripotency-associated genes such as ADP-ribosylation factor-like 6 interacting protein (ARMER), poly (rC) binding protein 1 (PCBP1) and pyruvate dehydrogenase E1-β subunit (PDHB) when subjected to the environment. Conclusion To our knowledge, this is the first study to demonstrate that non-SP single-clone cells can be induced to generate a SP phenotype when they are cultured with conditioned medium of macrophage-like cells, which is associated with the reactivation of pluripotency-associated genes.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Thu, 25 Feb 2010 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/242180</guid>
      <dc:date>2010-02-25T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Fusion genes in breast cancer</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/241721</link>
      <description>Title: Fusion genes in breast cancer
Authors: Batty, Elizabeth
Abstract: Fusion genes caused by chromosomal rearrangements are a common and important feature in&#xD;
haematological malignancies, but have until recently been seen as unimportant in epithelial&#xD;
cancers. The discovery of recurrent fusion genes in prostate and lung cancer suggests that&#xD;
fusion genes may play an important role in epithelial carcinogenesis, and that they have been&#xD;
previously under-reported due to the difficulties of cytogenetic analysis of solid tumours. In&#xD;
particular, breast cancers often have complex, highly rearranged karyotypes which have proved&#xD;
difficult to analyse using classical cytogenetic techniques.&#xD;
The aim of this project was to search for fusion genes in breast cancer by using high-resolution&#xD;
mapping of chromosome rearrangements in breast cancer cell lines. Mapping the chromosome&#xD;
rearrangements was initially done using high-resolution DNA microarrays and fluorescence in-&#xD;
situ hybridisation, but moved to high-throughput sequencing as it became available. Interesting&#xD;
candidate genes identified from the mapped chromosome rearrangements were investigated&#xD;
on a larger set of cell lines and primary tumours.&#xD;
The complete karyotypes of two breast cancer cell lines were constructed using a combination&#xD;
of microarrays, fluorescence microscopy, and high-throughput sequencing. A number of&#xD;
potential fusion genes were identified in these two cell lines. Although no expressed fusion&#xD;
genes were found, the complete karyotypes gave insight into the number and mechanisms of&#xD;
chromosome rearrangement in breast cancer, and identified interesting candidate genes which&#xD;
may be of importance in tumourigenesis. Two genes which were fused in other breast cancer&#xD;
cell lines, BCAS3 and ODZ4, were disrupted by chromosome rearrangements and identified as&#xD;
interesting candidate genes in tumorigenesis.&#xD;
A bioinformatic pipeline to process high-throughput sequencing data was set up and validated,&#xD;
and shown to more accurately predict fusion genes than other methods, and can be used to&#xD;
investigate further cell lines and tumours for recurrent fusion genes. The pipeline was used to&#xD;
analyse data from 3 other breast cancer cell lines and predict chromosomal rearrangements&#xD;
and fusion genes, several of which were found to be expressed. Of the fusions predicted in the&#xD;
cell line ZR-75-30, 7 expressed fusion genes were identified, and may have functional&#xD;
significance in breast cancer.</description>
      <pubDate>Tue, 07 Feb 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/241721</guid>
      <dc:date>2012-02-07T00:00:00Z</dc:date>
    </item>
    <item>
      <title>NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/241705</link>
      <description>Title: NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
Authors: de Kruijf, Esther M; Sajet, Anita; van Nes, Johanna GH; Putter, Hein; Smit, Vincent THBM; Eagle, Robert A; Jafferji, Insiya; Trowsdale, John; Liefers, Gerrit Jan; van de Velde, Cornelis JH; Kuppen, Peter JK
Abstract: Abstract Background Cell surface NKG2D ligands (NKG2DL) bind to the activating NKG2D receptor present on NK cells and subsets of T cells, thus playing a role in initiating an immune response. We examined tumor expression and prognostic effect of NKG2DL in breast cancer patients. Methods Our study population (n = 677) consisted of all breast cancer patients primarily treated with surgery in our center between 1985 and 1994. Formalin-fixed paraffin-embedded tumor tissue was immunohistochemically stained with antibodies directed against MIC-A/MIC-B (MIC-AB), ULBP-1, ULBP-2, ULBP-3, ULBP-4, and ULBP-5. Results NKG2DL were frequently expressed by tumors (MIC-AB, 50% of the cases; ULBP-1, 90%; ULBP-2, 99%; ULBP-3, 100%; ULBP-4, 26%; ULBP-5, 90%) and often showed co-expression: MIC-AB and ULBP-4 (p = 0.043), ULBP-1 and ULBP-5 (p = 0.006), ULBP-4 and ULBP-5 (p &lt; 0.001). MIC-AB (p = 0.001) and ULBP-2 (p = 0.006) expression resulted in a statistically significant longer relapse free period (RFP). Combined expression of these ligands showed to be an independent prognostic parameter for RFP (p &lt; 0.001, HR 0.41). Combined expression of all ligands showed no associations with clinical outcome. Conclusions We demonstrated for the first time that NKG2DL are frequently expressed and often co-expressed in breast cancer. Expression of MIC-AB and ULBP-2 resulted in a statistically significant beneficial outcome concerning RFP with high discriminative power. Combination of all NKG2DL showed no additive or interactive effect of ligands on each other, suggesting that similar and co-operative functioning of all NKG2DL can not be assumed. Our observations suggest that among driving forces in breast cancer outcome are immune activation on one site and tumor immune escape on the other site.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Wed, 18 Jan 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/241705</guid>
      <dc:date>2012-01-18T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Glycoprotein M and ESCRT in herpes simplex virus type 1 assembly</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/241516</link>
      <description>Title: Glycoprotein M and ESCRT in herpes simplex virus type 1 assembly
Authors: Ren, Yudan
Abstract: Herpes simplex virus type 1 (HSV-1) has a large linear double-stranded DNA genome in an icosahedral capsid shell, a cell-derived lipid envelope and a proteinaceous tegument layer. There are over fifty viral proteins and many host proteins identified in HSV-1 virions. The final formation of mature virus particles requires the membrane wrapping of tegumented capsids in the cytoplasm, a process termed secondary envelopment. This process involves the coordination of numerous viral and cellular proteins and results in double-membrane structures with enveloped virions contained within cellular vesicles. Mature viruses are then released through the fusion of these virion-containing vesicles and plasma membranes. This thesis describes investigation into the functions of viral glycoprotein M (gM) and the cellular Endosomal Sorting Complexes Required for Transport (ESCRT) in secondary envelopment.&#xD;
Firstly, it has been reported that gH/L can be efficiently internalised and targeted to the TGN by the co-expression of gM in transfection assays. In order to examine the role of gM in guiding the localisation of viral proteins in infected cells, a HSV-1 gM deletion virus (∆gM), and its revertant virus were constructed. The major phenotype demonstrated was that the absence of gM caused the internalisation of cell surface gH/L to be inhibited and higher levels of gH/L to be observed on the cell surface. Further, lower levels of gH/L were detected in purified ∆gM virions, which was in agreement with the delayed entry kinetics, smaller plaque sizes and greater replication deficits at low multiplicity of infection observed in ∆gM infected cells. Over all the results presented in this thesis demonstrate that in infected cells the efficient incorporation of gH/L into virions relies on the function of gM in HSV-1.&#xD;
Secondly, during HSV-1 secondary envelopment the budding and scission of the viral envelope from the host membrane share topological similarities with the formation of intraluminal vesicle in multivesicular bodies, retrovirus budding, and abscission at the end of cytokinesis, processes that require the cellular ESCRT machinery. There are four multiprotein ESCRT complexes and many associated proteins involved in their regulation. It has been previously shown that the ESCRT-III complex and a functional ATPase VPS4 are required for HSV-1 secondary envelopment, but different from the strategy utilised by HIV-1, the recruitment of ESCRT during HSV-1 infection is independent of TSG101 and/or ALIX. Data presented in this thesis demonstrate that CHMP4A/B/C proteins of the ESCRT-III complex are specifically crucial for HSV-1 secondary envelopment. Simultaneous depletion of CHMP4A/B/C proteins significantly inhibited HSV-1 replication. Ultrastructure analysis revealed that there were virtually no extracellular virions in CHMP4A/B/C depleted samples while more free capsids were observed in the cytoplasm, although the nuclear capsids and primary envelopment events appeared to be normal. In order to identify interactions between HSV-1 and ESCRT proteins, 22 HSV-1 tegument proteins were cloned and tested against a panel of ESCRT and ESCRT-associated proteins in yeast two-hydrid assays. Analysis of positive hits from yeast two-hybrid interaction screens using GST pull-down, co-immunoprecipitation and protein co-localisation assays have validated interactions of pUL47 with CC2D1A/1B, CIN85, CHMP6 and ALIX, pUL46 and pUL49 with CC2D1A/1B and CIN85, and pUL16 with CC2D1A/1B. Furthermore, the newly identified ESCRT associated proteins CC2D1A and CC2D1B have been detected in purified virions. The role of the identified ESCRT proteins in HSV-1 replication has been investigated using siRNA depletion. Unfortunately siRNA depletions of the various ESCRT candidates individually or in combinations did not show any significant effect on HSV-1 replication. Overall these data suggest that unlike HIV and other retroviruses, HSV-1 has evolved multiple parallel pathways to hijack the ESCRT machinery to facilitate its replication, particularly, through the interactions that lead directly to the recruitment of CHMP4A/B/C proteins. Disruption of some of these pathways did not prevent HSV-1 replication in tissue culture, suggesting any one potential pathway is sufficient for ESCRT recruitment to sites of HSV-1 assembly.</description>
      <pubDate>Tue, 10 Jan 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/241516</guid>
      <dc:date>2012-01-10T00:00:00Z</dc:date>
    </item>
    <item>
      <title>High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/240567</link>
      <description>Title: High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology
Authors: Crawford, Robin; Grignon, Anne-Laure; Kitson, Sarah; Winder, David M; Ball, Siolian L R; Vaughan, Katie; Stanley, Margaret A; Sterling, Jane C; Goon, Peter K C
Abstract: Abstract Background Human papillomaviruses (HPV) are causally associated with ano-genital and a subset of head and neck cancers. Rising incidence of HPV+ anal cancers and head and neck cancers have now been demonstrated in the developed world over the last decade. The majority of published data on HPV prevalence at the anal and oro-pharyngeal sites are from studies of higher-risk populations. There is a paucity of data on the prevalence of HPV at non-cervical sites in lower risk, non-HIV+ women and this study was designed to provide initial pilot data on a population of women recalled for colposcopy as part of the UK cervical screening programme. Methods 100 non-HIV+ women with abnormal cervical cytology, attending clinic for colposcopic examination were recruited. Swabs from the oro-pharyngeal, anal and cervical sites were taken and DNA extracted. HPV detection and genotyping were performed using a standardised, commercially available PCR-line blot assay, which is used to genotype 37 HPV subtypes known to infect the ano-genital and oro-pharyngeal areas. Strict sampling and laboratory precautions were taken to prevent cross-contamination. Results There was a very high prevalence of HPV infection at all three sites: 96.0%, 91.4% and 92.4% at the cervix, anus and oro-pharynx, respectively. Multiple HPV subtype infections were dominant at all 3 mucosal sites. At least one or more HR genotype was present at both the cervix/anus in 39/52 (75.0%) patients; both the cervix/oro-pharynx in 48/56 (85.7%) patients; and both the anus/oro-pharynx in 39/52 (75.0%) patients. HPV 16 infection was highly dominant across all mucosal sites, with over a 2-fold increase over the next most prevalent subtype (HPV 31). Conclusions Women with abnormal smears have widespread infection with high-risk HPV at the cervical, anal and oro-pharyngeal mucosal sites and may represent a higher risk population for HPV disease in the future.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Wed, 02 Nov 2011 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/240567</guid>
      <dc:date>2011-11-02T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The structure and evolution of breast cancer genomes</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/239397</link>
      <description>Title: The structure and evolution of breast cancer genomes
Authors: Newman, Scott
Abstract: Chromosome changes in the haematological malignancies, lymphomas and sarcomas are&#xD;
known to be important events in the evolution of these tumours as they can, for example,&#xD;
form fusion oncogenes or disrupt tumour suppressor genes. The recently described&#xD;
recurrent fusion genes in prostate and lung cancer proved to be iconic examples as they&#xD;
indicated that important gene fusions are found in the common epithelial cancers also.&#xD;
Breast cancers often display extensive structural and numerical chromosome aberration&#xD;
and have among the most complex karyotyes of all cancers. Genome rearrangements are&#xD;
potentially an important source of mutation in breast cancer but little is known about how&#xD;
they might contribute to this disease.&#xD;
My first aim was to carry out a structural survey of breast cancer cell line genomes in order&#xD;
to find genes that were disrupted by chromosome aberrations in “typical” breast cancers. I&#xD;
investigated three breast cancer cell lines, HCC1187, VP229 and VP267 using data from&#xD;
array painting, SNP6 array CGH, molecular cytogenetics and massively parallel paired end&#xD;
sequencing. I then used these structural genomic maps to predict fusion transcripts and&#xD;
demonstrated expression of five fusion transcripts in HCC1187, three in VP229 and four in&#xD;
VP267.&#xD;
Even though chromosome aberrations disrupt and fuse many genes in individual breast&#xD;
cancers, a major unknown is the relative importance and timing of genome&#xD;
rearrangements compared to sequence-level mutation. For example, chromosome&#xD;
instability might arise early and be essential to tumour suppressor loss and fusion gene&#xD;
formation or be a late event contributing little to cancer development.&#xD;
To address this question, I considered the evolution of these highly rearranged breast&#xD;
cancer karyotypes. The VP229 and VP267 cell lines were derived from the same patient&#xD;
before and after therapy-resistant relapse, so any chromosome aberration found in both&#xD;
cell lines was probably found in the common in vivo ancestor of the two cell lines. A large&#xD;
majority of structural variants detected by massively parallel paired end sequencing,&#xD;
including three fusion transcripts, were found in both cell lines, and therefore, in the&#xD;
common ancestor. This probably means that the bulk of genome rearrangement pre-dated&#xD;
the relapse.&#xD;
For HCC1187, I classified most of its mutations as earlier or later according to whether&#xD;
they occurred before or after a landmark event in the evolution of the genome -&#xD;
endoreduplication (duplication of its entire genome). Genome rearrangements and&#xD;
sequence-level mutations were fairly evenly divided between earlier and later, implying&#xD;
that genetic instability was relatively constant throughout the evolution of the tumour.&#xD;
Surprisingly, the great majority of inactivating mutations and expressed gene fusions&#xD;
happened earlier. The non-random timing of these events suggests many were selected.</description>
      <pubDate>Mon, 11 Jul 2011 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/239397</guid>
      <dc:date>2011-07-11T23:00:00Z</dc:date>
    </item>
    <item>
      <title>The tammar wallaby major histocompatibility complex shows evidence of past genomic instability</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/239040</link>
      <description>Title: The tammar wallaby major histocompatibility complex shows evidence of past genomic instability
Authors: Siddle, Hannah V; Deakin, Janine E; Coggill, Penny; Wilming, Laurens G; Harrow, Jennifer; Kaufman, Jim; Beck, Stephan; Belov, Katherine
Abstract: Abstract Background The major histocompatibility complex (MHC) is a group of genes with a variety of roles in the innate and adaptive immune responses. MHC genes form a genetically linked cluster in eutherian mammals, an organization that is thought to confer functional and evolutionary advantages to the immune system. The tammar wallaby (Macropus eugenii), an Australian marsupial, provides a unique model for understanding MHC gene evolution, as many of its antigen presenting genes are not linked to the MHC, but are scattered around the genome. Results Here we describe the 'core' tammar wallaby MHC region on chromosome 2q by ordering and sequencing 33 BAC clones, covering over 4.5 MB and containing 129 genes. When compared to the MHC region of the South American opossum, eutherian mammals and non-mammals, the wallaby MHC has a novel gene organization. The wallaby has undergone an expansion of MHC class II genes, which are separated into two clusters by the class III genes. The antigen processing genes have undergone duplication, resulting in two copies of TAP1 and three copies of TAP2. Notably, Kangaroo Endogenous Retroviral Elements are present within the region and may have contributed to the genomic instability. Conclusions The wallaby MHC has been extensively remodeled since the American and Australian marsupials last shared a common ancestor. The instability is characterized by the movement of antigen presenting genes away from the core MHC, most likely via the presence and activity of retroviral elements. We propose that the movement of class II genes away from the ancestral class II region has allowed this gene family to expand and diversify in the wallaby. The duplication of TAP genes in the wallaby MHC makes this species a unique model organism for studying the relationship between MHC gene organization and function.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Thu, 18 Aug 2011 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/239040</guid>
      <dc:date>2011-08-18T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on immune responses to schistosome antigens among the offspring: results of a randomised, placebo-controlled trial.</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/239024</link>
      <description>Title: Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on immune responses to schistosome antigens among the offspring: results of a randomised, placebo-controlled trial.
Authors: Tweyongyere, Robert; Mawa, Patrice A; Kihembo, Macklyn; Jones, Frances M; Webb, Emily L; Cose, Stephen; Dunne, David W; Vennervald, Birgitte J; Elliott, Alison M
Abstract: Abstract Background Offspring of women with schistosomiasis may exhibit immune responsiveness to schistosomes due to in utero sensitisation or trans-placental transfer of antibodies. Praziquantel treatment during pregnancy boosts maternal immune responses to schistosome antigens and reduces worm burden. Effects of praziquantel treatment during pregnancy on responses among offspring are unknown. Methods In a trial of anthelminthic treatment during pregnancy in Uganda (ISRCTN32849447; http://www.controlled-trials.com/ISRCTN32849447/elliott), offspring of women with Schistosoma mansoni were examined for cytokine and antibody responses to schistosome worm (SWA) and egg (SEA) antigen, in cord blood and at age one year. Relationships to maternal responses and pre-treatment infection intensities were examined, and responses were compared between the offspring of women who did, or did not receive praziquantel treatment during pregnancy. Results Of 388 S. mansoni-infected women studied, samples were obtained at age one year from 215 of their infants. Stool examination for S. mansoni eggs was negative for all infants. Cord and infant samples were characterised by very low cytokine production in response to schistosome antigens with the exception of cord IL-10 responses, which were substantial. Cord and infant cytokine responses showed no association with maternal responses. As expected, cord blood levels of immunoglobulin (Ig) G to SWA and SEA were high and correlated with maternal antibodies. However, by age one year IgG levels had waned and were hardly detectable. Praziquantel treatment during pregnancy showed no effect on cytokine responses or antibodies levels to SWA or SEA either in cord blood or at age one year, except for IgG1 to SWA, which was elevated in infants of treated mothers, reflecting maternal levels. There was some evidence that maternal infection intensity was positively associated with cord blood IL-5 and IL-13 responses to SWA, and IL-5 responses to SEA, and that this association was modified by treatment with praziquantel. Conclusions Despite strong effects on maternal infection intensity and maternal immune responses, praziquantel treatment of infected women during pregnancy had no effect on anti-schistosome immune responses among offspring by age one year. Whether the treatment will impact upon the offspring's responses on exposure to primary schistosome infection remains to be elucidated. Trial registration ISRCTN: ISRCTN32849447
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Thu, 01 Sep 2011 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/239024</guid>
      <dc:date>2011-09-01T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Rab23 is a flagellar protein in Trypanosoma brucei</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238466</link>
      <description>Title: Rab23 is a flagellar protein in Trypanosoma brucei
Authors: Lumb, Jennifer H; Field, Mark C
Abstract: Abstract Background Rab small GTPases are important mediators of membrane transport, and orthologues frequently retain similar locations and functions, even between highly divergent taxa. In metazoan organisms Rab23 is an important negative regulator of Sonic hedgehog signaling and is crucial for correct development and differentiation of cellular lineages by virtue of an involvement in ciliary recycling. Previously, we reported that Trypanosoma brucei Rab23 localized to the nuclear envelope 1 , which is clearly inconsistent with the mammalian location and function. As T. brucei is unicellular the potential that Rab23 has no role in cell signaling was possible. Here we sought to further investigate the role(s) of Rab23 in T. brucei to determine if Rab23 was an example of a Rab protein with divergent function in distinct taxa. Methods/major findings The taxonomic distribution of Rab23 was examined and compared with the presence of flagella/cilia in representative taxa. Despite evidence for considerable secondary loss, we found a clear correlation between a conventional flagellar structure and the presence of a Rab23 orthologue in the genome. By epitope-tagging, Rab23 was localized and found to be present at the flagellum throughout the cell cycle. However, RNAi knockdown did not result in a flagellar defect, suggesting that Rab23 is not required for construction or maintenance of the flagellum. Conclusions The location of Rab23 at the flagellum is conserved between mammals and trypanosomes and the Rab23 gene is restricted to flagellated organisms. These data may suggest the presence of a Rab23-mediated signaling mechanism in trypanosomes.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Tue, 14 Jun 2011 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238466</guid>
      <dc:date>2011-06-14T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Molecular Pathogenesis of MALT lymphoma</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238398</link>
      <description>Title: Molecular Pathogenesis of MALT lymphoma
Authors: Hamoudi, Rifat A
Abstract: Mucosa associated lymphoid tissue (MALT) lymphoma is characterized by t(11;18)(q21;q21)/API2-MALT1, t(1;14)(p22;q32)/BCL10-IGH and&#xD;
t(14;18)(q32;q21)/IGH-MALT1, which commonly activate the NF-κB pathway. Gastric MALT lymphomas harbouring such translocation do not respond to Helicobacter pylori eradication, while those without translocation can be cured by antibiotics.&#xD;
  &#xD;
To understand the molecular mechanism of MALT lymphoma with and without chromosome translocation, 24 cases (15 translocation-positive and 9 translocation-negative) of MALT lymphomas together with 7 follicular lymphomas and 7 mantle cell lymphomas were analysed by Affymetrix gene expression microarray platform.  Unsupervised clustering showed that cases of MALT lymphoma were clustered as a single branch.  However, within the MALT lymphoma group, translocation-positive cases were intermingled with translocation-negative cases. Gene set enrichment analysis (GSEA) of the NF-κB target genes and 4394 additional gene sets covering various cellular pathways, biological processes and molecular functions showed that translocation-positive MALT lymphomas were characterized by an enhanced expression of NF-κB target genes, particularly TLR6, CCR2, CD69 and BCL2, while translocation-negative cases were featured by active inflammatory and immune responses, such as IL8, CD86, CD28 and ICOS.  Separate analyses of the genes differentially expressed between translocation-positive and negative cases and measurement of gene ontology term in these differentially expressed genes by hypergeometric test reinforced the above findings by GSEA.  The differential expression of these NF-κB target genes between MALT lymphoma with and without translocation was confirmed by quantitative RT-PCR and immunohistochemistry or Western blot.&#xD;
&#xD;
Expression of TLR6, in the presence of TLR2, enhanced both API2-MALT1 and BCL10 mediated NF-κB activation in vitro.  In addition, there was cooperation between expression of BCL10, MALT1 or API2-MALT1, and stimulation of the antigen receptor or CD40 or TLR in NF-κB activation as shown by both reporter assay and IκBα degradation.  Interestingly, expression of BCL10 but not API2-MALT1 and MALT1, in the presence of LPS stimulation, also triggered IκBβ degradation, suggesting activation of different NF-κB dimers between these oncogenic products.    &#xD;
&#xD;
Study by co-immunoprecipitation showed that BCL10 directly interacts with MALT1. Sub-cellular localisation experiments in BJAB B-cells, showed that BCL10 localisation was affected by MALT1. When BCL10 was over-expressed, the protein was predominantly expressed in the nuclei, but when MALT1 was over-expressed, BCL10 was mainly localised in the cytoplasm. When both BCL10 and MALT1 were over-expressed, BCL10 was expressed in the cytoplasm in the early hours when the protein level was low, but in both the cytoplasm and nuclei after 9 hours when the protein level was high. Over-expression of API2-MALT1 did not shown any apparent effect on BCL10 sub-cellular localisation in vitro.&#xD;
&#xD;
Finally, comparison of MALT lymphoma expression microarray with other lymphomas showed lactoferrin to be highly expressed in MALT lymphoma. This was confirmed by qRT-PCR, showing lactoferrin to be significantly over-expressed in MALT lymphoma compared to FL and MCL. Thus lactoferrin may be a potential marker for MALT lymphoma.
Description: The original dissertation included a number or articles which were excluded from the digital file for copyright reasons. This is a list of the articles:; 1) 	Hamoudi RA, Appert A, Ye H, Ruskone-Fourmestraux A, Streubel B, Chott A, Raderer M, Gong L, Wlodarska I, De Wolf-Peeters C, MacLennan KA, de Leval L, Isaacson PG, &amp; Du MQ.&#xD;
	Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.&#xD;
	Leukemia. 2010 Aug;24(8):1487-1497&#xD;
&#xD;
http://www.ncbi.nlm.nih.gov/pubmed/20520640; 2) 	Ye H, Gong L, Liu H, Hamoudi RA, Shirali S, Ho L, Chott A, Streubel B, Siebert R, Gesk S, Martin-Subero JI, Radford JA, Banerjee S, Nicholson AG, Ranaldi R, Remstein ED, Gao Z, Zheng J, Isaacson PG, Dogan A &amp; Du MQ.&#xD;
	MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.&#xD;
	J Pathol. 2005 Feb;205(3):293-301.&#xD;
&#xD;
http://www.ncbi.nlm.nih.gov/pubmed/15682443; 3) 	Liu H, Hamoudi RA, Ye H, Ruskone-Fourmestraux A, Dogan A, Isaacson PG &#xD;
	&amp; Du MQ.&#xD;
	t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks.&#xD;
	Br J Haematol. 2004 May;125(3):318-329.&#xD;
http://www.ncbi.nlm.nih.gov/pubmed/15086412; 4) 	Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wündisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG &amp; Du MQ.&#xD;
	T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.&#xD;
	Gastroenterology. 2002 May;122(5):1286-1294.&#xD;
&#xD;
http://www.ncbi.nlm.nih.gov/pubmed?term=11984515; 5)      Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, Isaacson PG &amp; Du MQ.&#xD;
T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10.&#xD;
	Blood. 2001 Aug 15;98(4):1182-1187.&#xD;
&#xD;
http://www.ncbi.nlm.nih.gov/pubmed?term=11493468; 6) 	Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ &amp; Isaacson PG.&#xD;
	Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.&#xD;
	Lancet. 2001 Jan 6;357(9249):39-40.&#xD;
&#xD;
http://www.ncbi.nlm.nih.gov/pubmed?term=11197361</description>
      <pubDate>Fri, 01 Jan 2010 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238398</guid>
      <dc:date>2010-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238283</link>
      <description>Title: A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland
Authors: Gordon, Katrina E; Binas, Bert; Chapman, Rachel S; Kurian, Kathreena M; Clarkson, Richard W E; Clark, A John; Birgitte Lane, E; Watson, Christine J
Abstract: Abstract Background This paper describes the derivation and characterization of a novel, conditionally immortal mammary epithelial cell line named KIM-2. These cells were derived from mid-pregnant mammary glands of a mouse harbouring one to two copies of a transgene comprised of the ovine β-lactoglobulin milk protein gene promoter, driving expression of a temperature-sensitive variant of simian virus-40 (SV40) large T antigen (T-Ag). Results KIM-2 cells have a characteristic luminal epithelial cell morphology and a stable, nontransformed phenotype at the semipermissive temperature of 37°C. In contrast, at the permissive temperature of 33°C the cells have an elongated spindle-like morphology and become transformed after prolonged culture. Differentiation of KIM-2 cells at 37°C, in response to lactogenic hormones, results in the formation of polarized dome-like structures with tight junctions. This is accompanied by expression of the milk protein genes that encode β-casein and whey acidic protein (WAP), and activation of the prolactin signalling molecule, signal transducer and activator of transcription (STAT)5. Fully differentiated KIM-2 cultures at 37°C become dependent on lactogenic hormones for survival and undergo extensive apoptosis upon hormone withdrawal, as indicated by nuclear morphology and flow cytometric analysis. KIM-2 cells can be genetically modified by stable transfection and clonal lines isolated that retain the characteristics of untransfected cells. Conclusion KIM-2 cells are a valuable addition, therefore, to currently available lines of mammary epithelial cells. Their capacity for extensive differentiation in the absence of exogenously added basement membrane, and ability to undergo apoptosis in response to physiological signals will provide an invaluable model system for the study of signal transduction pathways and transcriptional regulatory mechanisms that control differentiation and involution in the mammary gland.</description>
      <pubDate>Tue, 07 Mar 2000 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238283</guid>
      <dc:date>2000-03-07T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Identification of Schistosoma mansoni gender-associated gene transcripts by cDNA microarray profiling</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238268</link>
      <description>Title: Identification of Schistosoma mansoni gender-associated gene transcripts by cDNA microarray profiling
Authors: Hoffmann, Karl F; Johnston, David A; Dunne, David W
Abstract: Abstract Background Parasitic helminths of the genus Schistosoma mate, achieve sexual maturity and produce eggs in the bloodstream of their definitive hosts, and the most important pathological consequences of the infection are associated with this process. We have used cDNA microarray technology to initiate genome-wide gene-expression studies of sex and sexual development in mature Schistosoma mansoni parasites. Results An S. mansoni-specific cDNA microarray was fabricated using 576 expressed sequence tags selected from three cDNA libraries and originating from two different parasite developmental stages. Five independent cDNA microarray hybridizations were analyzed using stringent filtering criteria and careful quality control, leading to the identification of 12 new female-associated and 4 new male-associated gene transcripts in the mature adult schistosome. Statistical analysis of variation demonstrated high levels of agreement within a cDNA microarray (correlation coefficient 0.91; median coefficient of variation 11.1%) and between cDNA microarrays (correlation coefficient 0.90; median coefficient of variation 14.4%). RT-PCR analysis confirmed the cDNA microarray results, thereby supporting the reliability of the system. Conclusions Our study expands the list of S. mansoni gender-associated gene transcripts from all previous studies by a factor of two. Among the new associations identified, a tyrosinase ortholog was preferentially expressed in the adult female, and a dynein light-chain ortholog was highly induced in the adult male. cDNA microarrays offer the potential for exponential leaps in the understanding of parasite biology and this study shows how molecules involved in sexual biology can be rapidly identified.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Wed, 24 Jul 2002 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238268</guid>
      <dc:date>2002-07-24T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Identification of novel Y chromosome encoded transcripts by testis transcriptome analysis of mice with deletions of the Y chromosome long arm</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238248</link>
      <description>Title: Identification of novel Y chromosome encoded transcripts by testis transcriptome analysis of mice with deletions of the Y chromosome long arm
Authors: Toure, Aminata; Clemente, Emily J; Ellis, Peter J; Mahadevaiah, Shantha K; Ojarikre, Obah A; Ball, Penelope; Reynard, Louise; Loveland, Kate L; Burgoyne, Paul S; Affara, Nabeel A
Abstract: Abstract Background The male-specific region of the mouse Y chromosome long arm (MSYq) is comprised largely of repeated DNA, including multiple copies of the spermatid-expressed Ssty gene family. Large deletions of MSYq are associated with sperm head defects for which Ssty deficiency has been presumed to be responsible. Results In a search for further candidate genes associated with these defects we analyzed changes in the testis transcriptome resulting from MSYq deletions, using testis cDNA microarrays. This approach, aided by accumulating mouse MSYq sequence information, identified transcripts derived from two further spermatid-expressed multicopy MSYq gene families; like Ssty, each of these new MSYq gene families has multicopy relatives on the X chromosome. The Sly family encodes a protein with homology to the chromatin-associated proteins XLR and XMR that are encoded by the X chromosomal relatives. The second MSYq gene family was identified because the transcripts hybridized to a microarrayed X chromosome-encoded testis cDNA. The X loci ('Astx') encoding this cDNA had 92-94% sequence identity to over 100 putative Y loci ('Asty') across exons and introns; only low level Asty transcription was detected. More strongly transcribed recombinant loci were identified that included Asty exons 2-4 preceded by Ssty1 exons 1, 2 and part of exon 3. Transcription from the Ssty1 promotor generated spermatid-specific transcripts that, in addition to the variable inclusion of Ssty1 and Asty exons, included additional exons because of the serendipitous presence of splice sites further downstream. Conclusion We identified further MSYq-encoded transcripts expressed in spermatids and deriving from multicopy Y genes, deficiency of which may underlie the defects in sperm development associated with MSYq deletions.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Fri, 02 Dec 2005 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238248</guid>
      <dc:date>2005-12-02T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Key stages in mammary gland development - Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238238</link>
      <description>Title: Key stages in mammary gland development - Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ
Authors: Watson, Christine J
Abstract: Abstract Involution of the mammary gland is an essential process that removes the milk-producing epithelial cells when they become redundant at weaning. It is a two-step process that involves the death of the secretory epithelium and its replacement by adipo-cytes. During the first phase, remodelling is inhibited and apoptotic cells can be seen in the lumena of the alveoli. In the second phase, apoptosis is accompanied by remodelling of the surrounding stroma and re-differentiation of the adipocytes. Considerable effort has been directed towards understanding the molecular mechanisms of the involution process and this has resulted in the identification of the principal signalling pathways involved.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Sun, 09 Apr 2006 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238238</guid>
      <dc:date>2006-04-09T23:00:00Z</dc:date>
    </item>
    <item>
      <title>High-throughput analysis of chromosome translocations and other genome rearrangements in epithelial cancers</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238179</link>
      <description>Title: High-throughput analysis of chromosome translocations and other genome rearrangements in epithelial cancers
Authors: Newman, Scott; Edwards, Paul A W
Abstract: Abstract Genes that are broken or fused by structural changes to the genome are an important class of mutation in the leukemias and sarcomas but have been largely overlooked in the common epithelial cancers. Large-scale sequencing is changing our perceptions of the cancer genome, and it is now being applied to structural changes, using the 'paired end' strategy. This reveals more clearly than before the extent to which many cancer genomes are rearranged and how much these rearrangements contribute to the mutational burden of epithelial tumors. In particular, there are probably many fusion genes, analogous to those found in leukemias, to be found in common cancers, such as breast carcinoma, and some of these will prove to be important in cancer diagnosis and treatment.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Wed, 17 Mar 2010 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238179</guid>
      <dc:date>2010-03-17T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238136</link>
      <description>Title: Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach
Authors: Stevens, James; Joly, Etienne; Trowsdale, John; Butcher, Geoffrey W
Abstract: Abstract Background Increasing evidence suggests that the effect of HLA-E on Natural Killer (NK) cell activity can be affected by the nature of the peptides bound to this non-classical, MHC class Ib molecule. However, its reduced cell surface expression, and until recently, the lack of specific monoclonal antibodies hinder studying the peptide-binding specificity HLA-E. Results An in vitro refolding system was used to assess binding of recombinant HLA-E to either specific peptides or a nonamer random peptide library. Peptides eluted from HLA-E molecules refolded around the nonamer library were then used to determine a binding motif for HLA-E. Hydrophobic and non-charged amino acids were found to predominate along the peptide motif, with a leucine anchor at P9, but surprisingly there was no methionine preference at P2, as suggested by previous studies. Conclusions Compared to the results obtained with rat classical class Ia MHC molecules, RT1-A1c and RT1-Au, HLA-E appears to refold around a random peptide library to reduced but detectable levels, suggesting that this molecule's specificity is tight but probably not as exquisite as has been previously suggested. This, and a previous report that it can associate with synthetic peptides carrying a viral sequence, suggests that HLA-E, similar to its mouse counterpart (Qa-1b), could possibly bind peptides different from MHC class I leader peptides and present them to T lymphocytes.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Tue, 19 Jun 2001 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238136</guid>
      <dc:date>2001-06-19T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238132</link>
      <description>Title: Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells
Authors: Vales-Gomez, Mar; Browne, Helena; Reyburn, Hugh T
Abstract: Abstract Background Human Cytomegalovirus (HCMV) has acquired through evolution a number of genes to try to evade immune recognition of the virus-infected cell. Many of these mechanisms act to inhibit the MHC class I antigen presentation pathway, but any virus-infected cell which has down-regulated cell surface expression of MHC class I proteins, to avoid CTL attack, would be expected to become susceptible to lysis by Natural Killer cells. Surprisingly, however, HCMV infected fibroblasts were found to be resistant to NK cell mediated cytotoxicity. Expression of the UL16 glycoprotein could represent one mechanism to help the virus to escape from NK cell attack, as it has been shown to bind, in vitro, some of the ligands for NKG2D, the NK cell activating receptor. Here, we explored the role of UL16, in the context of a viral infection, by comparing the susceptibility to NK lysis of cells infected with HCMV and cells infected with a UL16 deletion mutant of this virus. Results Cells infected with the UL16 knockout virus were killed at substantially higher levels than cells infected with the wild-type virus. This increased killing could be correlated with a UL16-dependent reduction in surface expression of ligands for the NK cell activating receptor NKG2D. Conclusions Expression of the UL16 glycoprotein was associated with protection of HCMV-infected cells from NK cell attack. This observation could be correlated with the downregulation of cell surface expression of NKG2D ligands. These data represent a first step towards understanding the mechanism(s) of action of the UL16 protein.
Description: RIGHTS : This article is licensed under the BioMed Central licence at  http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.  In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work  - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.</description>
      <pubDate>Fri, 14 Mar 2003 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238132</guid>
      <dc:date>2003-03-14T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Changes in IgE- and Antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238121</link>
      <description>Title: Changes in IgE- and Antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel
Authors: Satti, Mohamed Z; Cahen, Pierre; Skov, Per S; Joseph, Sarah; Jones, Frances M; Fitzsimmons, Colin; Hoffmann, Karl F; Reimert, Claus; Kariuki, Henry Curtis; Kazibwe, Francis; Mwatha, Joseph K; Kimani, Gachuhi; Vennervald, Birgitte J; Ouma, John H; Kabatereine, Narcis B; Dunne, David W
Abstract: Abstract Background Parasite-specific IgE levels correlate with human resistance to reinfection with Schistosoma spp. after chemotherapy. Although the role of eosinophils in schistosomiasis has been the focus of a great deal of important research, the involvement of other Fcε receptor-bearing cells, such as mast cells and basophils, has not been investigated in relation to human immunity to schistosomes. Chemotherapy with praziquantel (PZQ) kills schistosomes living in an in vivo blood environment rich in IgE, eosinophils and basophils. This releases parasite Ags that have the potential to cross-link cell-bound IgE. However, systemic hypersensitivity reactions are not induced by treatment. Here, we describe the effects of schistosomiasis, and its treatment, on human basophil function by following changes in total cellular histamine and in vitro histamine-release induced by schistosome Ags or anti-IgE, in blood samples from infected Ugandan fishermen, who are continuously exposed to S. mansoni infection, before and 1-day and 21-days after PZQ treatment. Results There was a significant increase in the total cellular histamine in blood samples at 1-day post-treatment, followed by a very significant further increase by 21-days post-treatment. In vitro histamine-release induced by S. mansoni egg (SEA) or worm (SWA) Ags or anti-IgE antibody, was significantly reduced 1-day post-treatment. The degree of this reduction correlated with pre-treatment infection intensity. Twenty-1-days post-treatment, SEA-induced histamine-release was still significantly lower than at pretreatment. Histamine-release was not correlated to plasma concentrations of total or parasite-specific IgE, nor to specific IgG4 plasma concentrations. Conclusion The biology of human blood basophils is modulated by S. mansoni infection and praziquantel treatment. Infection intensity-dependent suppression of basophil histamine-release, histamine-dependent resistance to infection, and similarities with allergen desensitisation are discussed as possible explanations of these observations.</description>
      <pubDate>Tue, 20 Apr 2004 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238121</guid>
      <dc:date>2004-04-20T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Micro-geographical variation in exposure to Schistosoma mansoniand malaria, and exacerbation of splenomegaly in Kenyan school-aged children</title>
      <link>http://www.dspace.cam.ac.uk:80/handle/1810/238120</link>
      <description>Title: Micro-geographical variation in exposure to Schistosoma mansoniand malaria, and exacerbation of splenomegaly in Kenyan school-aged children
Authors: Booth, Mark; Vennervald, Birgitte J; Kenty, LeeCarol; Butterworth, Anthony E; Kariuki, Henry Curtis; Kadzo, Hilda; Ireri, Edmund; Amaganga, Clifford; Kimani, Gachuhi; Mwatha, Joseph; Otedo, Amos; Ouma, John H; Muchiri, Eric; Dunne, David W
Abstract: Abstract Background Schistosoma mansoni and Plasmodium falciparum are common infections of school aged children in Kenya. They both cause enlargement of the spleen, but their relative contribution to the condition of splenomegaly remains unknown in areas where both infections are endemic. Here, we have investigated whether relatively high exposure to both infections has a clinically measurable effect on this condition. Methods 96 children aged 6–16 years living along a ten kilometre stretch and within 4 km south of a river that is a source of both S. mansoni and malaria infections were examined clinically for splenomegaly along the mid clavicular line (MCL) and mid axillary line (MAL). The survey was conducted outside the malaria transmission season. The consistency of the organ was recorded as soft, firm or hard. Mapping of the locations of houses and the course of the river was undertaken. Egg counts were mapped at the household level, as were IgG3 responses to Plasmodium falciparum schizont antigen (anti-Pfs IgG3), in order to identify areas with relatively high exposure to both infections, either infection or neither infection. ANOVA was used to test for differences in egg counts, IgG3 levels and the magnitude of spleen enlargement between these areas. Results 4 contiguous sectors were identified, one where anti-Pfs IgG3 responses and S. mansoni egg counts were both high, one where only anti-Pfs IgG3 responses were high, one where only egg counts were high, and one where both anti-Pfs IgG3 responses and egg counts were low. Spleen MAL and MCL values were significantly higher amongst children from the sector with highest IgG3 levels and highest egg counts but similar amongst children from elsewhere. Both egg counts and anti-Pfs IgG3 responses were significantly higher in children with MAL values &gt;=4 cm. Hardening of spleens was associated with proximity of domicile to the river. Conclusions Micro-geographical variation in exposure to S. mansoni and malaria infections can be exploited to investigate the chronic impact of these two infections. These results provide firm evidence that relatively high exposure to both infections exacerbates splenomegaly even outside the malaria transmission season. Major implications include assessing the burden of infection in school age-children.</description>
      <pubDate>Sun, 16 May 2004 23:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.dspace.cam.ac.uk:80/handle/1810/238120</guid>
      <dc:date>2004-05-16T23:00:00Z</dc:date>
    </item>
  </channel>
</rss>

